Roche extends tender offer for Spark Therapeutics By: MarketWatch December 09, 2019 at 02:16 AM EST The period for Roche’s offer of $114.50 per share for U.S.-based Spark has been extended several times and was set to expire on Dec. 10. Read More >> Related Stocks: Spark Therap
